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Open abdominal aortic aneurysm repair in
octogenarians before and after the adoption of
endovascular grafting procedures
Enzo Ballotta, MD,a Giuseppe Da Giau, MD,a Alessio Bridda, MD,b Mario Gruppo, MD,b Alberto
Pauletto, MD,b and Bruno Martella, MD,b Padova, Italy
Objective: This study evaluated (1) elective open abdominal aortic aneurysm repair (OAR) in patients aged >80 years
before and after stent graft devices for endovascular aneurysm repair (EVAR) became commercially available and (2) the
effect on perioperative (30-day) outcome of the anatomic constraints that led to EVAR being excluded for many of them.
Methods: A review was conducted on the records of 111 patients aged >80 years who underwent elective OAR during a
14-year period at the University of Padua School of Medicine. Patients were separated into two groups: group 1 (n 65)
had OAR before and group 2 (n  46) after an EVAR program was adopted at the medical school in mid-2000.
Perioperative death and morbidity, location of proximal aortic clamp, management of the left renal vein, associated iliac
aneurysmal or occlusive diseases, the type of surgical reconstruction, operating time, and lengths of stay in the intensive
care unit and the hospital were recorded. All the data were compared between the two groups.
Results: Retroperitoneal approach, suprarenal clamping, left renal vein division, and longer operating room time were
statistically more common in group 2 (36.9% vs 12.3%, P .002; 15.2% vs 3.1%, P .032; 23.9% vs 7.7%, P .026; and
117  8 min vs 95 7 min, P < .001, respectively). Although group 2 had significantly more iliac aneurysms (52.1% vs
32.3%; P .036), the number of bifurcated reconstructions was comparable. The overall perioperative mortality rate was
1.8% (2 of 111), and the figures for groups 1 and 2 were comparable (3.1% vs 0%; P  .510). No deaths were cardiac
related. Group 2 had a significantly higher incidence of kidney failure (8.7% vs 0%; P  .027). Kaplan-Meier analysis
showed an overall 3-, 5-, and 10-year survival rate of 80.6%, 67.2%, and 59.4%, respectively, with a 3- and 5-year survival
rate comparable between groups 1 and 2 (77.8% and 66.7% vs 87.8% and 45.8%, respectively; log-rank test, P  .921).
Conclusions: Octogenarians can tolerate OAR with acceptable rates of perioperative mortality and morbidity. Although
the complexity of OAR has increased significantly in the era of EVAR, the perioperative outcome has not changed.
(J Vasc Surg 2008;47:23-30.)Abdominal aortic aneurysm (AAA) is an age-related
disease accounting for 1% to 2% of all deaths.1 Longevity
has increased in the last century, and survival 80 years is
now common in all industrialized countries.2 As a greater
proportion of the population lives longer, it is realistic to
expect more elderly people to be considered for AAA
repair. Although morbidity and mortality rates after AAA
repair have continued to drop significantly during the last
decades,3-5 octogenarians are generally approached with
reserve when it comes to the surgical management of AAA
because the medical comorbidities so often accompanying
older age (rather than age in itself) are commonly consid-
ered significant risk factors for major surgery.6
In the current era of endovascular alternatives to the
treatment of aneurysmal disease, debate is evolving about
whether high-risk patients with an AAA, such as elderly
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doi:10.1016/j.jvs.2007.08.054patients, are best treated with an open (OAR) or an endo-
vascular AAA repair (EVAR), although it is commonly
assumed that the less-invasive nature of EVAR makes it
particularly suited to patients at high risk of faring poorly
with OAR.7
EVAR is not currently applicable to all patients,
however, for a variety of anatomic reasons, including
inadequate size of the AAA neck (absent, too short, too
large, or flared) or excessive angulation that precludes
satisfactory proximal fixation, or owing to the associated
presence of iliac aneurysmal (uncertain distal fixation and
risk for pelvic ischemia) or iliac occlusive diseases (diffi-
cult vascular access), or both.8-10 These constraints may
mean that many patients cannot be considered for EVAR
and have to be recommended for OAR, thus influencing
patient selection and modifying the technical manage-
ment of OAR, that is, the more anatomically favorable
AAA is repaired by EVAR and the more complex AAA is
left to OAR.
This study evaluated the perioperative (30-day) and
long-term outcomes of patients aged 80 years who un-
derwent OAR at University of Padua School of Medicine
before and after stent graft devices for EVAR become
commercially available and analyzed whether the anatomic
conditions that ruled out EVAR could affect the perioper-
ative outcome.
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Patients. Since 1992, pertinent clinical data for all
consecutive patients undergoing elective OAR of infrarenal
and juxtarenal AAA at our institution have been prospec-
tively entered into a computer-based vascular registry. By
definition, an AAA is considered juxtarenal if it does not
involve the renal arteries but extends proximally up to their
origin, leaving no space for infrarenal aortic clamping and
requiring either suprarenal or supravisceral cross-clamping
for proximal control; in pararenal AAAs, one or both renal
arteries are involved in the AAA, making their reimplanta-
tion necessary.11
The database was queried to identify patients aged 80
years who underwent OAR during the study period (1992-
2005), and particularly before (group 1) and after (group
2) an EVAR program began at the University of Padua
School of Medicine in mid-2000. Patients with a ruptured
AAA or who needed an emergency operation, patients with
suprarenal or pararenal AAA, and those who required late
conversions secondary to the EVAR failure were excluded
from the analysis. The study was undertaken in compliance
with the local ethical committee standards.
During the study period, many octogenarians with an
infrarenal AAA 5.5 cm maximum diameter on ultrasound
scan at the time of their first examination, referred to our
institution specifically for an opinion concerning the surgi-
cal repair of their AAA, were turned down for surgery by an
experienced vascular surgeon on clinical grounds alone.
Patients with impaired mental faculties, malignancies with a
poor life expectancy, or severe cardiovascular or respiratory
function impairments were considered too ill for surgery
and discouraged from OAR or, in the second half of the
study period, offered an EVAR procedure. In dubious
cases, patients were admitted to the hospital for cardiac and
respiratory assessment, and a consultant vascular anesthetist
reviewed their cases. All patients were informed about the
pros and cons of OAR by the same vascular surgeon, and
some patients considered the risk of the surgical procedure
unacceptable and refused OAR.
Demographic variables, preoperative risk factors and
comorbidities, the American Society of Anesthesiology
(ASA) classification, and perioperative outcomes of the
study patients were obtained from the database and supple-
mented from the hospital’s computer-based medical record
system and chart review.
Between August 2000 and December 2005, 13 octo-
genarians with AAAs were treated with EVAR. Demo-
graphic and risk factors data were collected on these pa-
tients and compared with the data for the OAR population
in group 2.
Risk factors. To define the cardiac risk, cardiovascular
history was carefully assessed, and resting electrocardio-
gram (ECG) and transthoracic Doppler echocardiograms
were obtained in all cases. Cardiac disease included a history
of myocardial infarction (MI), a positive exercise test result,
chest pain due to ischemia, atrial fibrillation, coronary
artery angioplasty/stenting or bypass grafting (CABG),surgery for valve disease or signs of ischemia on ECG, and
nitrate therapy.
All patients with a history suggestive of coronary artery
disease (CAD) or with abnormalities revealed by the ECG
were examined before OAR by a consultant from the cardiol-
ogy division, whose assessment sometimes prompted nonin-
vasive testing of left ventricular function or coronary perfusion
using dipyridamole-thallium scan or dobutamine stress echo-
cardiography. Patients with positive noninvasive test results
generally underwent cardiac catheterization to determine any
presence and severity of CAD or valvular heart disease. Ac-
cording to the results of this evaluation, patients with CAD
that could be revascularized were generally treated with cor-
onary artery angioplasty/stenting or CABG before OAR.
Patients who had previously undergone CABG were exam-
ined as described when they were clinically symptomatic or
when the CABG had been performed 2 years before OAR.
The medical therapy for patients not requiring revascu-
larization or with CAD that could not be revascularized was
optimized before OAR. Dobutamine stress echocardiogra-
phy revealed abnormalities in 29 patients (26.1%), and they
were evaluated with coronary angiography before OAR.
Significant CAD was diagnosed in 11 (9.9%), who under-
went either CABG (n  7) or coronary angioplasty (n  4)
at median of 5 months before OAR. Three other patients
were diagnosed with severe valvular disease, and they un-
derwent valvular replacement.
Pulmonary disease was defined as a history of chronic
restrictive or obstructive disease based on pulmonary func-
tion tests, pulmonary embolism, or prior lobectomy or
pneumonectomy. Chronic kidney disease (CKD) was de-
fined as a serum creatinine level 1.5 mg/dL in either
conservative or dialysis treatment.
Data collection. Two surgeons collected data from
the surgical reports, paying attention to the location of the
proximal aortic clamp, the need to divide the left renal vein
(LRV) close to the vena cava, the concomitant presence of
aneurysmal or occlusive disease, and the type of reconstruc-
tion. To assess any problem situations in the surgical pro-
cedure due to particular anatomic or technical features
capable of affecting the perioperative outcome, these tech-
nical data were analyzed for the two periods. The AAA
proximal neck features (length 15 mm; diameter 29
mm; angulation 60°) and other reasons why EVAR had
been ruled out for most of the octogenarians who then
underwent OAR were also recorded.
Arteriography and computed tomography (CT) or
magnetic resonance imaging (MRI) scans were obtained in
most patients early in the study period, whereas CT orMRI
scans alone were used in the latter part of the study.
Surgical procedure. All OARs were performed under
general anesthesia by the same surgeon, and an epidural
catheter was used for postoperative pain management in
most patients. Repair was usually through a transabdominal
approach, although a left retroperitoneal access was used in
many patients. All patients received a radial artery catheter
and were intravenously administered heparin (5000 U)
before aortic cross-clamping; heparinization was never re-
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Patients who required suprarenal clamping were adminis-
tered furosemide and mannitol before aortic clamping.
Selective renal perfusion was not used. A cell saver was used
routinely. Operating room time, intensive care unit stay,
and hospital length of stay were also recorded.
Study end point. The primary end point was periop-
erative death and major complications. Cardiac complica-
tions were classified by the consultant cardiologist and
included (1) MI with a diagnosis based on creatinine ki-
nase-MB levels and ECG findings, (2) pulmonary edema
confirmed by chest radiography, (3) documented ventric-
ular fibrillation or primary cardiac arrest, and (4) new
complete heart failure requiring a pacemaker. A postoper-
ative ECG was routinely obtained in all patients with a
history of CAD, congestive heart failure (CHF), or arrhyth-
mia (rhythm other than sinus). Cardiac isoenzymes were
obtained in all patients who had new findings at postoper-
ative ECG.
Pulmonary adverse events were defined as respiratory
failure requiring intubation for 2 days or reintubation,
noncardiogenic pulmonary edema, lobar pneumonia con-
firmed by chest radiography and requiring antibiotic ther-
apy, and pulmonary embolism documented by autopsy,
angiography, or a high-probability ventilation-perfusion
scan. An acute renal dysfunction was defined as an increase
in serum creatinine level of 2.0 mg/dL in conservative
treatment. Additional outcomes included overall complica-
tions, 6-month mortality, and 10-year cumulative survival.
Our practice is to see patients with uncomplicated
conditions at 6 months, 1 year, and then every 3 to 5 years
with a CT scan of the descending thoracic aorta and the
visceral aortic segment to rule out any new proximal aneu-
rysms. Complete follow-up information was collected by
review of the outpatient records and a telephone canvass of
patients, their surviving family members, or their referring
physicians.
Statistical analysis. The Student t test was used for
continuous data and the 2 analysis or Fisher exact test (two
tailed), as appropriate, for categoric data. Kaplan-Meier
life-table analysis was used to estimate survival rates, and
curves were compared with the log-rank test. Significance
was inferred at P  .05. Cox proportional hazards multi-
variate analysis was used to determine which factors with
statistical or marginal significance at univariate analysis
could influence the perioperative and postoperative out-
come.
RESULTS
During the study period, 11 octogenarians (9 before
and 2 after adopting the EVAR procedure) were turned
down for surgery, and eight (all in group 1) refused OAR.
Elective OAR was performed in 111 patients aged 80
years, and 46 (41.4%) were in group 2. The preoperative
demographic data, risk factors, and some anatomic and
operative features of the two groups are shown in Tables I
and II. The differences between the two groups in terms of
their demographic and risk factor data were not statisticallysignificant. The mean age was 84.1  2.3 years in group 1
(range, 80 to 91 years) and 83.7  2.8 years (range, 81 to
90 years) in group 2. The size of the AAA (transverse
diameter) was statistically larger in group 1 (7.2  1.5 cm
vs 6.7  0.4 cm, P  .020). A retroperitoneal approach,
suprarenal cross-clamping, and LRV division were statisti-
cally more frequent in group 2 (36.9% vs 12.3%, P .002;
15.2% vs 3.1%; P  .032, and 23.9% vs 7.7%; P  .026,
respectively).
Although the incidence of occlusive arterial disease did
not change during the two periods, group 2 had a signifi-
cantly higher rate of associated iliac aneurysms (52.1% vs
32.3%; P .036). The number of aortoaortic (tube graft),
and aortofemoral or aortoiliac reconstructions was compa-
rable for the two groups. The operating time was signifi-
cantly longer in group 2 (117 8 min vs 95 7 min, P
.001), but both groups had comparable the lengths of stay
in the intensive care unit and the hospital. The reasons why
group 2 patients were unfit for EVAR are summarized in
Table III.
During the second half of the study period, 13 octoge-
narians were treated with EVAR in addition to the 46 who
had OAR, representing 22% of all AAAs treated. These
patients were a mean 1 year older than group 2 patients and
had a significantly higher incidence of diabetes mellitus
(61.5% vs 23.9%, P  .018). The incidence of CKD and
pulmonary disease was lower in the EVAR group and
higher for concomitant PAD and ASA score 3, but the
Table I. Demographics and risk factors of patients
undergoing open abdominal aortic aneurysm repair
Characteristics*
All patients (N  111)
PGroup 1† Group 2†
Total 65 (58.6) 46 (41.4)
Age, y 84.09  2.3 83.7  2.8 .388
Male 46 (70.1) 33 (71.7) .912
AAA size, cm 7.2  1.5 6.7  0.4 .020‡
Risk factors
Smoking 50 (76.9) 29 (63.0) .112
Diabetes 24 (36.9) 11 (23.9) .146
Hyperlipidemia 14 (21.5) 9 (19.5) .801
Hypertension 37 (56.9) 22 (47.8) .344
Cardiac disease 29 (44.6) 18 (39.1) .565
CKD 11 (16.9) 8 (17.4) .949
Pulmonary disease 25 (38.5) 18 (39.1) .943
Concomitant
PAD
28 (43.1) 20 (43.4) .966
CVD 19 (29.2) 14 (30.4) .891
ASA score 3 24 (35.3) 12 (28.2) .230
AAA, Abdominal aortic aneurysm; CKD, chronic kidney disease; PAD,
peripheral arterial disease; CVD, cerebrovascular disease; ASA, American
Society of Anesthesiologists.
*Continuous data are presented as mean  SD; categoric data as number
(%).
†Group 1 patients underwent open aneurysm repair before an endovascular
aneurysm repair program was established; group 2 had repair after the
program was established.
‡Statistically significant.differences did not reach statistical significance. The two
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sion, cardiac disease, and cerebrovascular disease.
Perioperative mortality and morbidity. No opera-
tive deaths occurred in groups 1 and 2. Two perioperative
deaths (1.8 %) occurred in group 1 (3.1% vs 0%; P  .510):
one patient died of multisystemic organ failure and the
other of pulmonary insufficiency secondary to an over-
whelming pneumonia (Table IV). The overall and major
morbidity rates were 26.1% and 5.4%, respectively. Details
of major and minor 30-day morbidities are listed in Table
IV. Although groups 1 and 2 had comparable overall major
Table II. Technical details and anatomic or operative
features of patients undergoing open abdominal aortic
aneurysm repair
Technical/operative details*
All patients (N  111)
PGroup 1† Group 2†
Total 65 (58.6) 46 (41.4)
Transperitoneal approach 57 (87.7) 29 (63.1) .002
Retroperitoneal approach 8 (12.3) 17 (36.9)
Infrarenal clamp 63 (96.9) 39 (84.8) .032
Suprarenal clamp 2 (3.1) 7 (15.2)
LRV division 5 (7.7) 11 (23.9) .026
Iliac aneurysm 21 (32.3) 24 (52.1) .036
Iliac occlusive disease 11 (16.9) 10 (21.7) .523
AF reconstruction 8 (12.3) 7 (15.2) .659
AI reconstruction 21 (32.3) 15 (26.7) .973
AA reconstruction 36 (55.3) 24 (52.1) .738
EBL, mean mL 1863 2169 .079
Operating time, min 95  7 117  8 .001
Length of stay, d
ICU 2.8  2 3.5  3 .143
Hospital 7.5  5 8.1  6 .567
AAA, abdominal aortic aneurysm; LRV, left renal vein; AF, aortofemoral;
AI, aortoiliac; AA, aortoaortic; EBL, estimated blood loss; ICU, intensive
care unit.
*Continuous data are presented as mean  SD; categoric data as number
(%).
†Group 1 patients underwent open aneurysm repair before an endovascular
aneurysm repair program was established; group 2 had repair after the
program was established.
Table III. Reasons for exclusion from endovascular
aneurysm repair
Criteria No. (%)
AAA neck anatomy 24 (52.2)
Absence of a neck 4
Short neck* 12
Large-diameter neck† 5
Angled neck (60°) 3
Iliac aneurysm 9 (19.6)
Iliac occlusive disease 6 (13.0)
Patient preference 5 (10.9)
Surgeon preference 2 (4.3)
AAA, Abdominal aortic aneurysm.
*Mean, 6 mm (range, 5-9 mm).
†Mean, 33 mm (range, 31-38 mm).morbidity (3.1% vs 8.7%, P  .230), the incidence ofkidney failure was significantly higher in group 2 (8.7% vs
0%, P  .027). Minor morbidity was similar (group 1, 20%
vs group 2, 21.7%; P  .824).
Long-term results. No deaths occurred at 6 months
in this series. There were 33 late deaths (30.2%) in the series
as a whole. The main causes were cardiac in 15 patients
(45.4%), consisting of 9 with MI, 5 with CHF, and 1
arrhythmia; cancer in 6 (18.2%); pulmonary in 3 (9.1%) and
renal in 1, due to a worsening renal insufficiency (3%).
Miscellaneous events were responsible for seven other
deaths (21.2%), and the cause of death was unavailable for
one patient (3%). Three patients in group 1 were lost
during a median follow-up of 27 months.
Kaplan-Meier analysis showed survival rates of 80.6% at
3 years, 67.2% at 5 years, and 59.4% at 10 years for the
whole series (Fig 1), with a comparable 3- and 5-year
survival rate of 77.8% and 66.7% for group 1 vs 87.8% and
45.8% for group 2 (log-rank test, P  .921; Fig 2). At
univariate analysis, only cardiac disease resulted a predictor
for late death, but this factor revealed no significant influ-
ence at multivariate analysis (Table V).
Late graft complications. Apart from the two pa-
tients who died perioperatively and the three lost to follow-
up, 106 patients were eligible for the assessment of late
complications after aortic replacement grafts. We identified
only two late graft complications (1.9%), including one
graft limb occlusion in a patient with an aortobifemoral
graft and one distal aortic pseudoaneurysm in a patient with
a tube graft insertion.
DISCUSSION
The AAA geriatric population is clearly a clinical chal-
lenge. Until a decade ago, no therapeutic alternative to
OAR was available for patients with AAA, and given results
of AAA natural history studies, watchful waiting would
seem an appropriate clinical recommendation for those
with the most extreme medical comorbidities, old age
being just one of the many potential risk factors. This
explains why 11 octogenarians with infrarenal AAA were
turned down for surgery during the study period and eight
refused OAR after a careful evaluation of the surgical risks.
Given its less-invasive nature, EVAR has expanded the
indications for repair, offering a relatively better chance for
those at higher risk for OAR of effectively excluding their
AAA and preventing rupture with a considerably lower
physiologic stress. In recent years, many patients aged80
years with AAA have specifically or exclusively requested
EVAR, having learned about this “less-invasive” treatment
from themedia or their personal physician; however, EVAR
can only be performed in patients with a specific aortic
anatomy. The decision whether or when to perform OAR
in octogenarians denied EVAR because of their aortic
anatomy ultimately lies with the patient after a thorough
discussion with the vascular surgeon of the risks of surgery
weighed against the risks of conservative management.
The main outcome of this study is a 1.8% overall
perioperative mortality rate, with a comparable mortality
rate between patients in groups 1 and 2 (3.1% vs 0%), a
neury
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reported by Rutherford and Krupski12 in a survey of 30
peer-reviewed reports from 1990 to 2002 on OAR per-
formed in elderly and younger patients at centers of excel-
lence with sizeable series (n  9291).
Although many authors reported a perioperative mor-
tality rate of 7% for octogenarians after OAR,13-16 we
found that such patients can tolerate OAR with acceptable
perioperative death rate, confirming the results obtained in
many early reports,7,17-25 which in some series even ap-
proached the results achieved in younger cohorts (Table
VI). In addition, the nil 6-month mortality rate was reas-
suring, meaning that the relative safety of surgery was not
limited to the first 30 days. Although the aim of our study
was not to compare OAR with EVAR, it may worth adding
that the perioperative mortality rate was comparable with
or better than that reported in recently published large
series concerning octogenarians treated with EVAR26,27;
Fig 1. Kaplan-Meier curve shows long-term survival of all the
patients. The percentage on the right represents the rate of
survival at 10 years. The standard error is 10% at each time
point in the curve (range, 0% to 9.2%). Raw numbers of the
patients at risk analyzed at each time point are provided below
Table IV. Perioperative morbidity and mortality
30-day outcome Group 1, No. (%)*
Total 65 (58.6)
Death 2 (3.1)
Major morbidity 2 (3.1)
Myocardial infarction 0
Renal failure 0
Pneumonia 2 (3.1)
Other (minor) morbidity 13 (20.0)
Iliac vein injury 0
Ureteral injury 0
Arrhythmia 4 (6.1)
Protracted ileus 3 (4.6)
Inguinal lymph leak 5 (7.7)
Peripheral emboli 1 (1.5)
*Group 1 patients underwent open aneurysm repair before an endovascular a
establishedthe figure.this is particularly noteworthy considering that the periop-
erative mortality rate was 0% in group 2, among which were
patients whose aortic anatomy precluded EVAR.
Although CAD is reported as the first cause of periop-
erative death in older patients undergoing OAR,6 and
patients with documented CAD at the time of OAR are
predicted to have shorter survival,28,29 the only two deaths
in our series were not cardiac-related, and there were no
major cardiac complications. Like other authors,13,23 we
also believe that optimizing preoperative cardiac status
contributes substantially to the safety of elective OAR in
elderly patients. That is why we adopted an aggressive
screening protocol to ensure an appropriate medical ther-
apy (statins or -blockers) or surgical treatment (coronary
artery angioplasty/stenting or CABG) before OAR, which
reduced the cardiac-related perioperative mortality and
Fig 2. Kaplan-Meier curves show long-term survival of patients in
groups 1 (diamonds) and 2 (squares). The percentages on the right
represent 5-year survival rates. The standard error is10% at each time
point in the group 1 curve (range, 0% to 5.8%). The standard error is less
than 10% until the 4-year point in the group 2 curve (range, 0% to 8.8%)
and 19.5% at the 5-year point. Raw numbers of the patients at risk
Group 2, No. (%)* Total, No. (%) P
46 (41.4)
0 2 (1.8) .510
4 (8.7) 6 (5.4) .230
0 0
4 (8.7) 4 .027
0 2 .510
10 (21.7) 23 (20.7) .824
2 (4.3) 2 .170
1 (2.2) 1 .414
1 (2.2) 5 .401
2 (4.3) 5 1
3 (6.5) 8 1
1 (2.2) 2 1
sm repair programwas established; group 2 had repair after the programwasanalyzed at each time point are provided below the figure.
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patients.
Our survival rates at 3, 5, and 10 years are significantly
better than those reported in many early institution-based
series13,16,22 in which the 5-year survival rate was always
50%. This probably reflects both the relatively good
general health of most of our patients (65% of them had
an ASA score 3) and the careful preoperative cardiac
management of such patients, focusing on CAD. Although
almost half of the late deaths were cardiac-related, our
findings are remarkably similar to those reported in patients
Table V. Univariate analysis of preoperative variables on
long-term survival
Variable P
Male gender .753
Smoking .290
Diabetes .246
Hyperlipidemia .526
Hypertension .151
Cardiac disease .045
Chronic kidney disease .384
Pulmonary disease .159
Concomitant PAD .348
Cerebrovascular disease .647
ASA score 3 .751
Transperitoneal approach .831
Retroperitoneal approach
Infrarenal clamp .835
Suprarenal clamp
Left renal vein division .277
Iliac aneurysm .773
Iliac occlusive disease .295
Aortofemoral reconstruction .882
Aortoiliac reconstruction .790
Aortoaortic reconstruction .628
PAD, peripheral arterial disease; ASA, American Society of Anesthesiolo-
gists.
Table VI. Data on perioperative mortality rate from
studies of octogenarians undergoing elective open
abdominal aortic aneurysm repair
First author Year Patients 30-day death (%)
Harris17 1986 34 2.9
Robson18 1989 14 0
Glock19 1990 29 6.9
Paty20 1993 77 2.6
Dean21 1993 18 5.6
O’Hara13 1995 94 9.6
Van Damme22 1998 52 5.7
Kazmers14 1998 206 8.3
Dardik15 1999 246 7.3
Sicard7 2001 38 5.3
Haug16 2005 105 10.5
Dainese23 2006 31 3.1
Costin24 2006 606 3.0
Manis25 2006 78 1.3
Present series 2007 111 1.8with perioperative diagnosis of CAD who had coronaryrevascularization before OAR. O’Hara et al13 reported a
5-year survival rate of 80% in 27 octogenarians who under-
went prior myocardial revascularization vs 38% for the 70
others who did not. More recently, Dainese et al23 re-
corded a 4-year survival rate of 81% in a series of 31
octogenarians who underwent OAR, and 6.5% of them
underwent myocardial revascularization before OAR.
Although the perioperative mortality and overall com-
plication rates were comparable between the two groups in
our study, managing theOAR after adopting EVAR proved
technically challenging. More than half of the group 2
patients were rejected for EVAR owing to unsuitable anat-
omy of the AAA neck, and this meant a different manage-
ment of the proximal aortic control, with significantly more
suprarenal cross-clamping and LRV division in group 2
(five and three times more often, respectively) and a signif-
icantly longer operating time.
Suprarenal cross-clamping reportedly coincides with a
higher perioperative rate of mortality and morbidity be-
cause it involves more complex surgical maneuvers, wider
dissections, and the temporary exclusion of the kidney from
blood flow,30 whereas LRV division has been identified as
an independent predictor of postoperative kidney fail-
ure.31,32 These maneuvers probably accounted for the sig-
nificantly higher incidence of transient kidney failure in
group 2 (overcome during the hospital stay, with no long-
term dysfunctions or need for dialysis) that is consistent
with the transient renal insufficiency found by Breckwoldt
et al30 in a study comparing infrarenal with suprarenal
cross-clamping during OAR and that confirms the deteri-
oration in renal function seen by other authors after LRV
division.31,32
Likewise, an unfavorable aortic neck anatomy requiring
pararenal exposure and suprarenal clamping accounted for
the statistically more frequent reliance on a retroperitoneal
approach in group 2. A similar figure was reported in a
landmark retrospective study by the Montefiore Medical
Center group33 focusing on the role of OAR in the endo-
vascular era and showing that the retroperitoneal approach
may be particularly useful to facilitate OAR in difficult
circumstances, enabling it to be performed with acceptable
mortality and morbidity rates.
Managing iliac aneurysms associated with infrarenal
AAA is likely to entail more complex reconstructions and
longer operating times, more intraoperative blood loss, and
the likelihood of neighboring venous and ureteral injury,
resulting in a higher rate of aortofemoral or aortoiliac
reconstructions. Iliac aneurysmal disease was statistically
more frequent in group 2, involving more than half the
patients, but although the minor perioperative morbidity
rate was higher in group 2, the difference was not statisti-
cally significant. In addition, although the number of bifur-
cated reconstructions was higher in group 2, the difference
was likewise not statistically significant. A possible explana-
tion for this finding lies in that most of the patients unfit for
EVAR because of an unsuitable neck anatomy may have
had more tube graft reconstructions that balanced the
JOURNAL OF VASCULAR SURGERY
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needed bifurcated reconstructions.
Our findings should be interpreted in the light of the
study’s limitations. First, although the data were collected
prospectively, the analysis is retrospective in nature.
Second, the study was conducted on a selected group of
relatively healthy patients with an active life and a longer
perceived life expectancy than the average for octogenari-
ans. They are not representative of the octogenarian popu-
lation with AAA as a whole because they reflect a preselec-
tion made by the physicians referring patients at our
institution, who probably chose patients with a longer life
expectancy, preferring medical management for patients
with multiple comorbidities and a worse general health.
Third, all OARs were performed electively by the same
surgeon. This may help to explain the low mortality and
morbidity rates, which cannot be influenced by having
excluding EVAR patients from the group 2 data because
they do not seem to be at higher risk than the group 2
patients, and why our results cannot be extrapolated to the
population in general.
The aim of the study, however, was to provide infor-
mation on the outcome of OAR in octogenarians. With the
ageing of our population and the rising numbers of elderly
people unfit for EVAR, the relevance of such information
can be expected to increase.
CONCLUSION
This study has shown that octogenarians may tolerate
OAR with acceptable perioperative mortality and morbid-
ity rates that could serve as a standard against which to
compare any alternative therapy and to bear in mind when
advocating nonoperative management or expanding the
indication for EVAR. Many octogenarians who are denied
EVAR because of their aortic anatomy still carry a relatively
low risk for OAR and can undergo this type of repair with
excellent results.
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